Tissue and Cell Extraction and Purification |
EP10011 |
Neuromics |
100 Tests |
EUR 763.2 |
All Competitors Laboratories manufactures the bibomol reagents distributed by Genprice. The Bibomol reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact All Competitors. Other Bibomol products are available in stock. Specificity: Bibomol Category:
Dog True insulin ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog True insulin ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Serum / Plasma information
BIBR-1048 |
A8381-10 |
ApexBio |
10 mg |
EUR 212.4 |
Description: Dabigatran etexilate is a potent, selective and competitive inhibitor of thrombin. It is an oral prodrug of dabigatran. |
BIBR-1048 |
A8381-5 |
ApexBio |
5 mg |
EUR 157.2 |
Description: Dabigatran etexilate is a potent, selective and competitive inhibitor of thrombin. It is an oral prodrug of dabigatran. |
BIBR-1048 |
A8381-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 199.2 |
Description: Dabigatran etexilate is a potent, selective and competitive inhibitor of thrombin. It is an oral prodrug of dabigatran. |
BIBR-1048 |
A8381-50 |
ApexBio |
50 mg |
EUR 547.2 |
Description: Dabigatran etexilate is a potent, selective and competitive inhibitor of thrombin. It is an oral prodrug of dabigatran. |
BIBP3226 |
E-3620.0001 |
Bachem |
1.0mg |
EUR 254.4 |
Description: Sum Formula: C27H31N5O3; CAS# [159013-54-4] net |
BIBP3226 |
E-3620.0005 |
Bachem |
5.0mg |
EUR 907.2 |
Description: Sum Formula: C27H31N5O3; CAS# [159013-54-4] net |
BIBW2992 (Tovok) |
1616-1 |
Biovision |
each |
EUR 255.6 |
BIBW2992 (Tovok) |
1616-5 |
Biovision |
each |
EUR 738 |
Nintedanib (BIBF 1120) |
A8252-25 |
ApexBio |
25 mg |
EUR 306 |
Description: Nintedanib (BIBF 1120) is an indolinone-derived oral active, triple angiokinase inhibitor of vascular endothelial growth factor receptor (VEGFR)1-3, fibroblast growth factor receptor (FGFR)1-3 and platelet-derived growth factor receptor (PDGFR)?/?1. |
Nintedanib (BIBF 1120) |
A8252-5 |
ApexBio |
5 mg |
EUR 184.8 |
Description: Nintedanib (BIBF 1120) is an indolinone-derived oral active, triple angiokinase inhibitor of vascular endothelial growth factor receptor (VEGFR)1-3, fibroblast growth factor receptor (FGFR)1-3 and platelet-derived growth factor receptor (PDGFR)?/?1. |
Nintedanib (BIBF 1120) |
A8252-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 282 |
Description: Nintedanib (BIBF 1120) is an indolinone-derived oral active, triple angiokinase inhibitor of vascular endothelial growth factor receptor (VEGFR)1-3, fibroblast growth factor receptor (FGFR)1-3 and platelet-derived growth factor receptor (PDGFR)?/?1. |
Nintedanib (BIBF 1120) |
A8252-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Nintedanib (BIBF 1120) is an indolinone-derived oral active, triple angiokinase inhibitor of vascular endothelial growth factor receptor (VEGFR)1-3, fibroblast growth factor receptor (FGFR)1-3 and platelet-derived growth factor receptor (PDGFR)?/?1. |
Afatinib (BIBW2992) |
A8247-10 |
ApexBio |
10 mg |
EUR 265.2 |
Description: Afatinib (BIBW2992), an irreversible inhibitor of the ErbB family of tyrosine kinases, downregulates ErbB signalling by binding to the kinase domains of epidermal growth factor receptor (EGFR)/ human epidermal growth factor receptor 2 (HER2) with IC50 of 0.5 nM and 14nM, respectively. |